arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Integra LifeSciences Holdings Corporation

IART Health Care Medical/Dental Instruments
$12.17
▲ +2.8% Today
as of Oct 23, 10:03 ET
Last 30 days -22.79% Sep 14 → Oct 23
$11.46 $12.85 $14.24 $15.63 $17.02 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$11.66
High
$12.36
Low
$11.66
Volume
$1M
Avg Vol
$931,907
Mkt Cap
$1.0B
P/E (TTM)
—
Beta
—
52w High
$20.49
52w Low
$8.70
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Oct 22 · 08:46 StockStory
IART Q3 deep dive: Cincinnati disruption and Tissue Reconstruction challenges weigh on outlook
Oct 22 · 07:17 Simply Wall St.
Integra LifeSciences (IART) Stock Price Sinks As Q3 Earnings Revive Refinancing Worries
Oct 21 · 21:26 StockStory
Why Integra LifeSciences (IART) stock is falling today
▸ Show all 25 press releases & news Free account →

IART earnings at a glance

The options market is pricing a move of about ±16.0% after the report, a range of roughly $10.22 to $14.12 from today's $12.17. Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±15.6% on average; after the most recent report on Jul 29, 2026 it moved -16.5%. That means options currently expect about the same movement than IART has typically delivered. IART beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 121%. The share price of $12.17 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$8.70
$20
29% of range
Avg surprise (last 6)
+13.2%
Avg reaction (last 6)
-5.5%
33% positive
Latest IV / EM
121%
EM ±16.0% · $13 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.16$0.09$0.33$0.58$0.83 Actual $0.29Actual $0.05Actual $0.24Actual $-0.04Actual $-0.16Actual $-0.14Actual $0.41Est $0.43Actual $0.45Est $0.43Actual $0.54Est $0.43Actual $0.83Est $0.79Actual $0.54Est $0.41Actual $0.56Est $0.48 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-484M$-253M$-22M$209M$440M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 29, 2026Jun/2026 $0.56 $0.48 +16.7% +6.7% -16.5% earnings
Tue May 5, 2026Mar/2026 $0.54 $0.41 +31.7% +31.7% +24.1% earnings
Thu Feb 26, 20268K 2026-02-26 $0.83 $0.79 +5.1% — -2.2% earnings
Thu Oct 30, 2025Sep/2025 $0.54 $0.43 +25.6% — -23.5% earnings
Thu Jul 31, 2025Jun/2025 $0.45 $0.43 +4.7% — +6.2% earnings
Mon May 5, 2025Mar/2025 $0.41 $0.43 -4.7% — -21.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.14 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.16 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.04 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.24 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.05 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.29 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$419M$392M—$402M$416M$383M—$381M
Cost of revenue$199M$175M—$195M$206M$188M—$181M
Gross profit————————
Operating income$19M$11M—$12M$-513M$-15M—$-8M
Net income$4M$-5M—$-5M$-484M$-25M—$-11M
EPS (diluted)$0.06$-0.06—$-0.07$-6.31$-0.33—$-0.14

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$214M$237M$235M$232M$218M$239M$246M$215M
Inventory$492M$495M$493M$489M$465M$445M$429M$437M
Total current assets$1.19B$1.17B$1.16B$1.14B$1.14B$1.11B$1.08B$1.10B
Total assets$3.56B$3.58B$3.60B$3.65B$3.67B$4.05B$4.04B$4.07B
Long-term debt$707M$717M—$736M$746M$756M—$765M
Total liabilities$2.52B$2.54B$2.56B$2.61B$2.63B$2.53B$2.49B$2.54B
Total equity$1.04B$1.04B$1.04B$1.04B$1.04B$1.52B$1.55B$1.52B

Implied volatility — last 90 days

56%170%284%397%511% Jun 09 — IV 87% · EM ±10.9%Jun 10 — IV 94% · EM ±11.1%Jun 16 — IV 139% · EM ±8.2%Jun 19 — IV 82% · EM ±18.1%Jun 22 — IV 57% · EM ±11.9%Jun 23 — IV 99% · EM ±20.4%Jun 24 — IV 93% · EM ±18.6%Jun 25 — IV 94% · EM ±18.5%Jun 26 — IV 69% · EM ±13.2%Jun 29 — IV 116% · EM ±20.5%Jun 30 — IV 126% · EM ±21.7%Jul 01 — IV 114% · EM ±19.0%Jul 06 — IV 121% · EM ±16.8%Jul 07 — IV 145% · EM ±19.2%Jul 08 — IV 118% · EM ±14.7%Jul 13 — IV 238% · EM ±19.9%Jul 14 — IV 195% · EM ±14.1%Jul 20 — IV 75% · EM ±17.7%Jul 21 — IV 71% · EM ±16.6%Jul 22 — IV 95% · EM ±21.8%Jul 23 — IV 117% · EM ±26.4%Jul 24 — IV 87% · EM ±19.2%Jul 27 — IV 96% · EM ±20.1%Jul 28 — IV 64% · EM ±13.0%Jul 29 — IV 84% · EM ±16.8%Jul 30 — IV 75% · EM ±14.6%Jul 31 — IV 118% · EM ±22.5%Aug 03 — IV 75% · EM ±13.3%Aug 04 — IV 107% · EM ±18.4%Aug 05 — IV 102% · EM ±17.0%Aug 06 — IV 112% · EM ±18.1%Aug 07 — IV 121% · EM ±18.8%Aug 10 — IV 137% · EM ±18.9%Aug 13 — IV 74% · EM ±8.8%Aug 14 — IV 143% · EM ±15.8%Aug 24 — IV 62% · EM ±12.9%Aug 25 — IV 79% · EM ±16.1%Aug 27 — IV 91% · EM ±17.8%Aug 28 — IV 56% · EM ±10.8%Aug 31 — IV 95% · EM ±16.8%Sep 01 — IV 110% · EM ±19.0%Sep 02 — IV 110% · EM ±18.4%Sep 03 — IV 100% · EM ±16.1%Sep 04 — IV 80% · EM ±12.6%Sep 07 — IV 91% · EM ±12.6%Sep 08 — IV 154% · EM ±20.3%Sep 09 — IV 128% · EM ±16.0%Sep 10 — IV 90% · EM ±10.6%Sep 11 — IV 169% · EM ±18.7%Sep 14 — IV 133% · EM ±11.1%Sep 17 — IV 512% · EM ±21.4%Sep 21 — IV 103% · EM ±21.5%Sep 22 — IV 111% · EM ±22.8%Sep 24 — IV 80% · EM ±15.7%Sep 25 — IV 120% · EM ±23.0%Sep 28 — IV 135% · EM ±24.0%Oct 02 — IV 88% · EM ±13.7%Oct 06 — IV 121% · EM ±16.0%

Sector peers

PRCT
PROCEPT BioRobotics Corporation
$1.0B $20.06+9.8%
AORT
Artivion, Inc.
$1.1B $23.86+4.2%
BBNX
Beta Bionics, Inc.
$952M $19.36+5.2%
BVS
Bioventus Inc.
$1.1B $15.07+5.8%
IRMD
iRadimed Corporation
$1.1B $87.61-0.2%
TNDM
Tandem Diabetes Care, Inc.
$1.1B $16.99+3.9%

IART earnings FAQ

What is IART's expected move for earnings?

Options currently price a move of about ±16.0%, or $1.95 per share either way from $12.17.

How does IART stock usually react to earnings?

Across the last 6 reports the average next-day move was ±15.6%, up 2 times and down 4 times.

What is IART's implied volatility?

IART's at-the-money implied volatility is about 121% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in